Faculty profile

Yasser Riazalhosseini

ResearcherHuman GeneticsMcGill University

This profile is built from public research funding records (CIHR, NSERC and SSHRC) and PubMed. We have not imported them from a McGill University directory, so their courses may be missing. Find their university profile.

Yasser Riazalhosseini

Researcher

Human Genetics

Health Sciences

McGill University

Montreal, Quebec, Canada

Supervision signals

Has led research grants, which requires an independent research appointment. Ask their department whether they supervise graduate students.
26 publications in the last five years, latest in 2026.
Senior (last) author on 3 recent papers, a sign of leading a research group.
Principal investigator on 3 research grants (3 CIHR), most recently in 2017.
Supervisor on 1 trainee award (1 CIHR), most recently in 2018.

These signals come from public records, including CIHR, NSERC and SSHRC funding decisions. Ask the professor or the graduate program whether they are taking new students.

Academic metrics

Publications

Collaborators

Grants

Publications by year

Counts cover the publications linked to this profile. Citations and the h-index appear when the source records them.

Profiles and links

Search on Google Scholar

Find them onX · LinkedIn · Bluesky · YouTube

Signals and details

Research

Bioinformatics Cancer Genomics Computational Biology Functional Genomics Gene Regulation Microrna Mrna Stability Rna-Seq Analysis

Latest papers

Lysyl oxidase inhibition disrupts mitochondrial homeostasis to create vulnerability to ferroptosis in TNBC.
Cell reports. Medicine · 2026
Renal Cell Carcinoma: Histopathology, Molecular Features, and the Emerging Role of Organoid Models.
Gene · 2026 · senior author
Airway microbiome diversity, intramucosal bacteria, and spatial immunity in asthmatic adults and controls.
American journal of respiratory and critical care medicine · 2026

All 59 publications

Latest funding

Advancing Risk Stratification in Young Women at High Risk for Breast Cancer
CIHR · 2025 · Co-investigator
$999,975
Targeting exosomal mediators of vascular pathology in glioblastoma
CIHR · 2022 · Co-investigator
$956,250
Protein glycation acts as a substrate-dependent tumorigenic molecular switch in prostate cancer
CIHR · 2021 · Co-investigator
$1,132,200

All 11 grants and awards

59 publications.

Lysyl oxidase inhibition disrupts mitochondrial homeostasis to create vulnerability to ferroptosis in TNBC.

Saatci O, Ulukan B, Cetin M, Kuasne H, Martinez C, Percin E, Oleinik N, Savoca MT, Nehme A, Hernández-Corchado A, Zavacky E, Sreenivas K, Rezaeian AH, Bethard JR, Anoma JS, Sahin OS, Aguilar-Mahecha A, Buchanan M, Aras M, DeBlois G, Basik M, Hill EG, Ball LE, Rao CN, McInnes C, Riazalhosseini Y, Najafabadi HS, Lemasters JJ, Ogretmen B, Park M, Sahin O

Cell reports. Medicine2026

DOI: 10.1016/j.xcrm.2026.103015 PMID: 42673947

Renal Cell Carcinoma: Histopathology, Molecular Features, and the Emerging Role of Organoid Models.

Coppola AK, Shahini A, Mehrjoo Z, Tarikere S, Tanguay S, Riazalhosseini Y

Gene2026Senior author

DOI: 10.1016/j.gene.2026.150216 PMID: 42142672

Airway microbiome diversity, intramucosal bacteria, and spatial immunity in asthmatic adults and controls.

Moffatt MF, Nishimura T, Cox MJ, McBrien C, Burke C, Cuthbertson L, Lewis K, Attanoos R, Davies GA, Chung KF, Robertus JL, Ish-Horowicz J, O'Carroll O, Bozeman JM, McGowan A, Hopkin JM, Lathrop GM, Riazalhosseini Y, Cookson WOC

American journal of respiratory and critical care medicine2026

DOI: 10.1093/ajrccm/aamag232 PMID: 42150103

FLCN-Mutated Tumors in Smith-Magenis Syndrome: A Case Report of FLCN-Associated Pathogenesis.

Pichette É, Shahini A, Kailasam S, Tanguay S, Foulkes WD, Riazalhosseini Y, Brimo F

International journal of surgical pathology2026

DOI: 10.1177/10668969251415520 PMID: 41823029

Lysyl oxidase drives ccRCC progression by coordinating HIF-2α transcription program with tumor microenvironment.

Ulukan B, Saatci O, Madrigal A, Kim M, Tian W, Soytas M, Mehrjoo Z, Sahin OS, Sreenivas K, Rao CN, Nishimura T, Pillon V, Anoma JS, Hill E, Rak J, McInnes C, Park M, Brimo F, Tanguay S, Russell RC, Najafabadi H, Riazalhosseini Y, Sahin O

bioRxiv : the preprint server for biology2026

DOI: 10.64898/2026.07.24.739825 PMID: 42582009

Identification of Two Rare Variants in Iranian Families With Familial Sudden Cardiac Death.

Tahmasebivand M, Mehvari S, Ghodratpour F, Khoram Khorshid H, Malekzadeh R, Najafipour R, Riazalhosseini Y, Lathrop M, Najmabadi H, Kahrizi K

International journal of genomics2026

DOI: 10.1155/ijog/5965922 PMID: 41510139

Emerging roles of the cancerous inhibitor of protein phosphatase 2A (CIP2A) in ovarian cancer.

Filipe A, Saravi S, Mustafov D, Panfilov S, Banger S, Mousavikivaj S, Braoudaki M, Kailasam S, Riazalhosseini Y, Sahai MA, Drenos F, Sisu C, Karteris E

Scientific reports2025

DOI: 10.1038/s41598-025-05013-0 PMID: 40594400

Immune cell infiltration into brain tumor microenvironment is mediated by Rab27-regulated vascular wall integrity.

Adnani L, Meehan B, Kim M, Choi D, Rudd CE, Riazalhosseini Y, Rak J

Science advances2025

DOI: 10.1126/sciadv.adr6940 PMID: 40408475

Loss of VHL-mediated pRb regulation promotes clear cell renal cell carcinoma.

Akuma M, Kim M, Zhu C, Wiljer E, Gaudreau-Lapierre A, Patterson LD, Egevad L, Tanguay S, Trinkle-Mulcahy L, Stanford WL, Riazalhosseini Y, Russell RC

Cell death & disease2025

DOI: 10.1038/s41419-025-07623-y PMID: 40240354

Haplogroup Structure and Genetic Variation Analyses of Mitochondrial Genome SNPs in the Iranian Population.

Ghasemi M, Mohseni M, Fattahi Z, Edizadeh M, Beheshtian M, Keshavarzi F, Jalalvand K, Omrani M, Khanbazi A, Riazalhosseini Y, Akbari MR, Kahrizi K, Najmabadi H

Archives of Iranian medicine2025

DOI: 10.34172/aim.33639 PMID: 40298006

Advancing Risk Stratification in Young Women at High Risk for Breast Cancer

Co-investigatorCIHR2025Team Grant: Bringing Biology to Cancer Prevention - Breast Cancer

Principal investigators: Basik, Mark; Diorio, Caroline; Yaffe, Martin J

Keywords: Breast Cancer; Clinical Risk Factors; Digital Spatial Profiling; Genomics; Imaging; Microenvironment; Radiomics; Risk Stratification; Stroma; Young Women

$999,975

Targeting exosomal mediators of vascular pathology in glioblastoma

Co-investigatorCIHR2022Project Grant

Principal investigators: Rak, Janusz

Keywords: Angiogenesis; Blood Vessels; Brain Tumours; Egfr; Exosomes; Extracellular Vesicles; Glioblastoma; Glioma Stem Cells; Oncogenes; Thrombosis

$956,250

Protein glycation acts as a substrate-dependent tumorigenic molecular switch in prostate cancer

Co-investigatorCIHR2021Project Grant

Principal investigators: Labbé, David; Bordeleau, François

Keywords: Cancer Biology; Diet; Extracellular Matrix; Glycation; Mechanotransduction; Mouse Models; Prostate Cancer; Spatial Transcriptomics; Stiffness

$1,132,200

Identification of VHL-dependent dysfunction of the retinoblastoma protein in renal cancer RUNNING TITLE: Characterization of pRb dysfunction in RCC

Co-investigatorCIHR2021Project Grant

Principal investigators: Russell, Ryan

Keywords: Kidney Cancer; Oxygen-Sensing; Tumour Suppressors

$875,926

Characterization of oncogenic splicing pathways driven by RNA-binding proteins

Co-investigatorCIHR2020Project Grant

Principal investigators: Shateri Najafabadi, Hamed

Keywords: Bioinformatics; Cancer Genomics; Computational Biology; Functional Genomics; Gene Regulation; Rna Splicing; Rna-Binding Proteins; Systems Biology; Transcriptomics

$680,850

Modelling the regulatory networks that govern mRNA stability and their implication in cancer

SupervisorCIHR2018Doctoral Award - Frederick Banting and Charles Best Canada Graduate Scholarships

Principal investigators: Perron, Gabrielle

Keywords: Bioinformatics; Cancer; Computational Biology; Functional Genomics; Gene Regulation; Micro-Rnas; Mrna Stability; Post-Transcriptional Gene Regulation; Rna-Binding Proteins; Transcriptomics

$105,000

Genome-scale discovery of mechanisms for modulating oncogenic and tumour suppressor microRNAs

Principal investigatorCIHR2017Project Grant

Principal investigators: Shateri Najafabadi, Hamed; Riazalhosseini, Yasser

Keywords: Bioinformatics; Cancer Genomics; Computational Biology; Functional Genomics; Gene Regulation; Microrna; Mrna Stability; Rna-Seq Analysis

$233,325

Validating a promising targeted therapeutic approach in pancreatic cancer

Nominated PICIHR2016Operating Grant: Targeting High Fatality Cancers - Innovation Grant

Principal investigators: Riazalhosseini, Yasser

Keywords: Mouse Models; Pancreatic Cancer; Pdx; Therapeutic Target Validation

$99,372

Nanofluidic Wet-Cell for Genomic Analysis of Single Circulating Tumor Cells via Electron Microscopy

Co-investigatorNSERC2015Collaborative Health Research Projects

Principal investigators: Reisner, Walter

$179,233

Nanofluidic Wet-Cell for Genomic Analysis of Single Circulating Tumor Cells via Electron Microscopy

Principal investigatorCIHR2014Collaborative Health Research Projects (NSERC partnered)

Principal investigators: Reisner, Walter W; Hilke, Michael; Riazalhosseini, Yasser; Sladek, Robert G

Keywords: Circulating Tumor Cell; Electron-Microscopy; Graphene; Nanochannel; Nanofluidics; Single-Molecule; Wet-Cell

$358,467

From CIHR, NSERC and SSHRC funding decisions: CIHR since 2008, NSERC since 1991 and SSHRC since 1998, including their latest published competition results.

Something wrong or missing on this profile? Suggest a correction

Yasser Riazalhosseini

Research

Latest papers

Latest funding

Lysyl oxidase inhibition disrupts mitochondrial homeostasis to create vulnerability to ferroptosis in TNBC.

Renal Cell Carcinoma: Histopathology, Molecular Features, and the Emerging Role of Organoid Models.

Airway microbiome diversity, intramucosal bacteria, and spatial immunity in asthmatic adults and controls.

FLCN-Mutated Tumors in Smith-Magenis Syndrome: A Case Report of FLCN-Associated Pathogenesis.

Lysyl oxidase drives ccRCC progression by coordinating HIF-2&#x3b1; transcription program with tumor microenvironment.

Identification of Two Rare Variants in Iranian Families With Familial Sudden Cardiac Death.

Emerging roles of the cancerous inhibitor of protein phosphatase 2A (CIP2A) in ovarian cancer.

Immune cell infiltration into brain tumor microenvironment is mediated by Rab27-regulated vascular wall integrity.

Loss of VHL-mediated pRb regulation promotes clear cell renal cell carcinoma.

Haplogroup Structure and Genetic Variation Analyses of Mitochondrial Genome SNPs in the Iranian Population.

Nanofluidic Wet-Cell for Genomic Analysis of Single Circulating Tumor Cells via Electron Microscopy

Frequent collaborators

Mark Lathrop

Janusz Rak

Guillaume Bourque

Morag Park

Sidong Huang

Morag Park

Jacek Majewski

Alex Gregorieff

Kevin Petrecca

David Grynspan

Wassim Kassouf

Jun-Li Liu

Vanessa Dumeaux

Laura Trinkle-Mulcahy

Jason Karamchandani

Jason Karamchandani

Steven Gallinger

Paige McCallum

Eva Tomiak

Mark Basik

Monika Krzyzanowska

ATILLA Omeroglu

Tomi Pastinen

Sandra Turcotte

Michael Ohh

Celia Greenwood

Nada Jabado

Kevin Petrecca

Michael Witcher

Lysyl oxidase drives ccRCC progression by coordinating HIF-2α transcription program with tumor microenvironment.